Table 3 Surveys of hepatitis B virus surface antigen (HBsAg) and hepatitis C antibody (HCV Ab) prevalence in HIV-infected persons conducted in Kenya and neighboring sub-Saharan Africa countries, 1996-2013
| Â | Prevalence rates | ||||||
|---|---|---|---|---|---|---|---|
Author | Publication year | Country | Population | Sample size | HBsAg (%) | HCV (%) | HCV/HBV/HIV (%) |
Muriuki et al. (current study) | 2013 | Kenya | Outpatient | 300 | 6 | 10.3 | Â |
Mutuma et al.[34] | 2011 | Kenya | Outpatient | 51 | 8.8 | Â | Â |
Kapembwa et al.[19] | 2011 | Zambia | Inpatient | 323 | 9.9 | 2.2 | Â |
Moore et al.[26] | 2010 | Malawi | Inpatient | 300 | 6.7 | 5.7 | Â |
Di Bisceglie et al.[35] | 2010 | South Africa | Outpatient | 502 | 4.8 | Â | Â |
Mboto et al.[25] | 2010 | The Gambia | Outpatient | 1500 | Â | 0.6 | Â |
Kerubo et al.[23] | 2010 | Kenya | outpatients | Â | Â | 0.7 | 0.3 |
Belay et al.[36] | 2010 | Ethiopia | Blood donors | 6321 | 4.7 | 0.7 | Â |
Lukhwareni et al.[37] | 2009 | South Africa | Outpatient | 192 | 22.9 | Â | Â |
Oshitani et al.[38] | 1996 | Zambia | Outpatient | 340 | 7.1 | Â | Â |
Harania et al.[22] | 2008 | Kenya | Outpatient | 378 | 6.1 | 1.1 | Â |
Nyirenda et al.[27] | 2008 | Malawi | Inpatient | 226 | 17.5 | 4.5 | Â |
Otegbayo et al.[28] | 2008 | Nigeria | Outpatient | 1779 | 11.9 | 4.8 | Â |
Diop-Niaye et al.[30] | 2008 | Senegal | Outpatient | 363 | 16.8 | 1.6 | Â |
Shimeli et al.[39] | 2008 | Ethiopia | Outpatient | 305 | 3.9 | Â | Â |
Fimhaber et al.[35] | 2008 | South Africa | Outpatient | 502 | 4.8 | Â | Â |
Hoffmann et al.[40] | 2008 | South Africa | Outpatient | 537 | 19.7 | Â | Â |
Nagu et al.[20] | 2008 | Tanzania | Outpatient | 260 | 17.3 | 18.1 | Â |
Pirillo et al.[29] | 2007 | Uganda | Antenatal | 164 | 4.9 | 0.6 | Â |
Telatela et al.[32] | 2007 | Tanzania | Outpatient | Â | 15 | 13.8 | Â |
Lesi et al.[41] | 2007 | Nigeria | outpatients | 240 | 9.2 | 5.8 | 1.5 |
Pirillo et al.[29] | 2007 | Rwanda | antenatal | 82 | 2.4 | 4.9 | Â |
Wester et al.[42] | 2006 | Botswana | Outpatient | 160 | 10.6 | Â | Â |
Okoth et al.[43] | 2006 | Kenya | Outpatient | Â | 15 | Â | Â |
Otedo et al.[44] | 2004 | Kenya | Outpatient | 599 | 47 | Â | 53 |
Ejele et al.[45] | 2004 | Nigeria | outpatient | 342 | 9.7 | Â | 1 |
Rouet et al.[24] | 2004 | Cote d’Ivoire | Antenatal | 501 | 9 | 1.2 |  |
Mustapha et al.[46] | 2004 | Gombe Nigeria | outpatients | 200 | 26.5 | Â | Â |
Kallestrup et al.[31] | 2003 | Zimbabwe | Outpatient | 124 | Â | 0.8 | Â |
Kasolo et al.[47] | 2003 | Zambia | Antenatal | 214 | 31.3 | Â | Â |
Ampofo et al.[42] | 2002 | Nigeria | blood donors | Â | 15 | 8.4 | Â |
Sud et al.[48] | 2001 | Nigeria | outpatients | 80 | 22.2 | Â | Â |
Lodenyo et al.[44] | 2000 | South Africa | Outpatient | 100 | 6 | 1 | Â |
Rahlenbeck et al.[49] | 1997 | Ethiopia | outpatients | 2186 | 14.4 | Â | Â |
Oshitani et al.[38] | 1996 | Zambia | Outpatient | 340 | 7.1 | Â | Â |
Fainboim et al.[33] | 1999 | Argentina | outpatients | 484 | 14.5 | 58.5 | Â |